Mark Lowdell News Today

INmune Bio, Inc. (NASDAQ:INMB) Q4 2023 Earnings Call Transcript March 28, 2024 INmune Bio, Inc. beats earnings expectations. Reported EPS is $-0.47, expectations were $-0.58. INMB isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, greetings and welcome […]

INmune Bio, Inc. (NASDAQ:INMB) Q3 2023 Earnings Call Transcript November 1, 2023 INmune Bio, Inc. beats earnings expectations. Reported EPS is $-0.00048, expectations were $-0.39. Operator: Greetings and welcome to the INmune Bio Third Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal […]

Analysts at Robert W. Baird initiated coverage on shares of INmune Bio (NASDAQ:INMB – Get Rating) in a note issued to investors on Wednesday, The Fly reports. The firm set an “outperform” rating on the stock. INmune Bio Stock Down 3.7 % Shares of INMB traded down $0.29 during mid-day trading on Wednesday, reaching $7.58. […]

Analysts at Robert W. Baird initiated coverage on shares of INmune Bio (NASDAQ:INMB – Get Rating) in a note issued to investors on Wednesday, The Fly reports. The firm set an “outperform” rating on the stock. INmune Bio Stock Down 3.7 % Shares of INMB traded down $0.29 during mid-day trading on Wednesday, reaching $7.58. […]

Presidential Plenary Lecture to be Presented Wednesday, May 31 at the ICST Opening Session BOCA RATON, Fla., May 24, 2023 --  INmune Bio Inc. announces that Mark Lowdell,... | June 11, 2023

Represents First Ever Natural Killer Immunotherapy trial in Metastatic Castration-Resistant Prostate CancerWebinar at 11AM ET on Friday, May 12. BOCA RATON, Fla., May 08, 2023 --... | May 8, 2023

Company to Host Conference Call Today, May 3, at 4:30pm ET...

INmune Bio (NASDAQ:INMB – Get Rating) is scheduled to be posting its quarterly earnings results after the market closes on Wednesday, May 3rd. Parties that are interested in participating in the company’s conference call can do so using this link. INmune Bio (NASDAQ:INMB – Get Rating) last released its quarterly earnings data on Thursday, March […]

INmune Bio, Inc. (NASDAQ:NASDAQ:INMB) Q3 2022 Results Conference Call November 02, 2022 04:30 PM ET Company Participants David Moss - Chief Financial Officer Dr.

Equities analysts expect INmune Bio, Inc. (NASDAQ:INMB – Get Rating) to report earnings of ($0.60) per share for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for INmune Bio’s earnings. INmune Bio reported earnings of ($0.32) per share during the same quarter last year, which would indicate a negative year over […]